Serious gastric ulcer event after stereotactic body radiotherapy (SBRT) delivered with concomitant vinorelbine in a patient with left adrenal metastasis of lung cancer

References

• Onishi H, Shirato H, Nagata Y, Hiraoka M, Fujino M, Gomi K, . Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: Updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2007;2:S94–100.
   PubMed Web of Science ®Google Scholar
• Nagata Y, Takayama K, Matsuo Y, Norihisa Y, Mizowaki T, Sakamoto T, . Clinical outcomes of a phase I/II study of 48Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005;63:1427–31.
   PubMed Web of Science ®Google Scholar
• Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, . Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010;303:1070–6.
   PubMed Web of Science ®Google Scholar
• Takeda A, Takahashi M, Kunieda E, Takeda T, Sanuki N, Koike Y, . Hypofractionated stereotactic radiotherapy with and without transarterial chemoembolization for small hepatocellular carcinoma not eligible for other ablation therapies: Preliminary results for efficacy and toxicity. Hepatol Res 2008;36:60–9.
   Google Scholar
• Méndez Romero A, Wunderink W, Hussain SM, De Pooter JA, Heijmen BJ, Nowak PC, . Stereotactic body radiotherapy for primary and metastatic liver tumors: A single institution phase I-II study. Acta Oncol 2006;45:831–7.
   PubMed Web of Science ®Google Scholar
• Hoyer M, Roed H, Sengelov L, Traberg A, Ohlhuis L, Pedersen J, . Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma. Radiother Oncol 2005;76:48–53.
   PubMed Web of Science ®Google Scholar
• Milano MT, Katz AW, Zhang H, Okunieff P. Oligometastases treated with stereotactic body radiotherapy: Long-term follow-up of prospective study. Int J Radiat Oncol Biol Phys Epub 2011 Dec 13.
   Google Scholar
• Siva S, MacManus M, Ball D. Stereotactic radiotherapy for pulmonary oligometastases: A systematic review. J Thorac Oncol 2010;5:1091–9.
   PubMed Web of Science ®Google Scholar
• Torok J, Wegner RE, Burton SA, Heron DE. Stereotactic body radiation therapy for adrenal metastases: A retrospective review of a noninvasive therapeutic strategy. Future Oncol 2011;7:145–51.
   PubMedGoogle Scholar
• Chawla S, Chen Y, Katz AW, Muhs AG, Philip A, Okunieff P, . Stereotactic body radiotherapy for treatment of adrenal metastases. Int J Radiat Oncol Biol Phys 2009;75:71–5.
   PubMed Web of Science ®Google Scholar
• Casamassima F, Livi L, Masciullo S, Menichelli C, Masi L, Meattini I, . Stereotactic radiotherapy for adrenal gland metastases: University of Florence Experience. Int J Radiat Oncol Biol Phys Epub 2011 Feb 5.
   Google Scholar
• Bradley J. Radiographic response and clinical toxicity following SBRT for stage I lung cancer. J Thorac Oncol 2007;2:S118–24.
   PubMedGoogle Scholar
• Song DY, Benedict SH, Cardinale RM, Chung TD, Chang MG, Schmidt-Ullrich RK. Stereotactic body radiation therapy of lung tumors: Preliminary experience using normal tissue complication probability-based dose limits. Am J Clin Oncol 2005;28:591–6.
   PubMed Web of Science ®Google Scholar
• Pettersson N, Nyman J, Johansson KA. Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: A dose- and volume-response analysis. Radiother Oncol 2009;91:360–8.
   PubMed Web of Science ®Google Scholar
• Milano MT, Constine LS, Okunieff P. Normal tissue toxicity after small field hypofractionated stereotactic body radiation. Radiat Oncol 2008;3:36.
   PubMed Web of Science ®Google Scholar
• Timmerman R, Bastasch M, Saha D, Abdulrahman R, Hittson W, Story M. Optimizing dose and fractionation for stereotactic body radiation therapy. Normal tissue and tumor control effects with large dose per fraction. Front Radiat Ther Oncol 2007;40:352–65.
   PubMedGoogle Scholar
• Katoh N, Onimaru R, Sakuhara Y, Abo D, Shimizu S, Taguchi H, . Real-time tumor-tracking radiotherapy for adrenal tumors. Radiother Oncol 2008;87:418–24.
   PubMed Web of Science ®Google Scholar
• Onishi H, Kawakami H, Marino K, Komiyama T, Kuriyama K, Araya M, . A simple respiratory indicator for irradiation during voluntary breath holding: A one-touch device without electronic materials. Radiology 2010;255:917–23.
   PubMedGoogle Scholar
• Chawla S, Chen Y, Katz AW, Muhs AG, Philip A, Okunieff P, . Stereotactic body radiotherapy for treatment of adrenal metastases. Int J Radiat Oncol Biol Phys 2009; 75:71–5.
   PubMed Web of Science ®Google Scholar
• Casamassima F, Livi L, Masciullo S, Menichelli C, Masi L, Meattini I, . Stereotactic radiotherapy for adrenal gland metastases: University of Florence experience. Int J Radiat Oncol Biol Phys 2012;82:919–23.
   PubMed Web of Science ®Google Scholar
• Oberdiac P, Mineur L. Normal tissue tolerance to external beam radiation therapy: The stomach. Cancer Radiother 2010;14:336–9.
   PubMedGoogle Scholar
• Hoyer M, Roed H, Sengelov L, Traberg A, Ohlhuis L, Pedersen J, . Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma. Radiother Oncol 2005;76:48–53.
   PubMed Web of Science ®Google Scholar
• Kopek N, Holt MI, Hansen AT, Høyer M. Stereotactic body radiotherapy for unresectable cholangiocarcinoma. Radiother Oncol 2010;94:47–52.
   PubMed Web of Science ®Google Scholar
• Wilkowski R, Thoma M, Weingandt H, Dühmke E, Heinemann V. Chemoradiation for ductal pancreatic carcinoma: Principles of combining chemotherapy with radiation, definition of target volume and radiation dose. JOP 2005;6:216–30.
   PubMedGoogle Scholar